Company’s Phylosopher technology has been chosen as the central management and infrastructure solution.

Swiss-based computational biology provider Genedata is participating in BaSysBio, an integrated systems biology project involving 15 research organizations from nine European countries.

BaSysBio (Bacillus Systems Biology) will study the global regulation of gene transcription in the model bacterium Bacillus subtilis. This bacterium has significant economic potential as a producer of enzymes and metabolites and is used in a wide range of industries. Bacillus anthracis and Staphylococcus aureus are objects of research as well.

BaSysBio’s goal is to provide new insight into the fundamental principles that control cellular processes. Subsequently, the initiative will contribute to the identification of new biomarkers and innovative therapeutic targets for antibacterial drugs.

Genedata Phylosopher has been chosen as the central management and infrastructure solution for sharing and interpreting the experimental data generated within BaSysBio. The project will adapt an array of high-throughput genomics technologies, including transcriptomics, proteomics, metabolomics, fluxomics, and cell reporter assays.

Previous articleNovo Nordisk Reports Disappointing Results from Phase III Trial in Brain Hemorrhage
Next articleVaccinex and Teva Ink Antibody Development Alliance in MS and Oncology